Selected research
Market Structure
Global Tissue and Organ Transplantation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Tissue and Organ Transplantation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Tissue and Organ Transplantation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Tissue and Organ Transplantation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tissue and Organ Transplantation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Tissue and Organ Transplantation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tissue and Organ Transplantation include Arthrex, Biolife Solutions, Discovery Life Sciences, Medtronic, Stryker Corporation, Teva Pharmaceuticals, Veloxis Pharmaceutical, Zimmer Biomet and Abbvie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Tissue and Organ Transplantation market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Tissue and Organ Transplantation and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Tissue and Organ Transplantation revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Tissue and Organ Transplantation market size, projected growth trends, production technologies, key applications, and end-use industries.
Tissue and Organ Transplantation Segment by Company
Arthrex
Biolife Solutions
Discovery Life Sciences
Medtronic
Stryker Corporation
Teva Pharmaceuticals
Veloxis Pharmaceutical
Zimmer Biomet
Abbvie
Novartis
Tissue and Organ Transplantation Segment by Type
Preservation Solution
Immunosuppressive Drugs
Tissue Products
Tissue and Organ Transplantation Segment by Application
Hospital
Transplant Centers
Others
Tissue and Organ Transplantation Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue and Organ Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tissue and Organ Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue and Organ Transplantation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tissue and Organ Transplantation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tissue and Organ Transplantation industry.
Chapter 3: Detailed analysis of Tissue and Organ Transplantation companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tissue and Organ Transplantationrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Preservation Solution
- Immunosuppressive Drugs
- Tissue Products
Applications
- Hospital
- Transplant Centers
- Others
Companies covered
- Arthrex
- Biolife Solutions
- Discovery Life Sciences
- Medtronic
- Stryker Corporation
- Teva Pharmaceuticals
- Veloxis Pharmaceutical
- Zimmer Biomet
- Abbvie
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Tissue and Organ Transplantation Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Preservation Solution
- 1.2.3 Immunosuppressive Drugs
- 1.2.4 Tissue Products
- 1.3 Market Analysis by Application
- 1.3.1 Global Tissue and Organ Transplantation Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Transplant Centers
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Tissue and Organ Transplantation Growth Trends by Region
- 1.5.1 Global Tissue and Organ Transplantation Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Tissue and Organ Transplantation Market Size by Region (2021-2026)
- 1.5.3 Tissue and Organ Transplantation Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Tissue and Organ Transplantation Market Dynamics
- 2.1 Tissue and Organ Transplantation Industry Trends
- 2.2 Tissue and Organ Transplantation Industry Drivers
- 2.3 Tissue and Organ Transplantation Industry Opportunities and Challenges
- 2.4 Tissue and Organ Transplantation Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Tissue and Organ Transplantation Revenue by Company (2021-2026)
- 3.2 Global Tissue and Organ Transplantation Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Tissue and Organ Transplantation Key Company Head office and Area Served
- 3.4 Global Tissue and Organ Transplantation Company, Product Type & Application
- 3.5 Global Tissue and Organ Transplantation Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Tissue and Organ Transplantation Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Tissue and Organ Transplantation Players Market Share by Revenue in 2025
- 3.6.3 2025 Tissue and Organ Transplantation Tier 1, Tier 2, and Tier 3
4 Tissue and Organ Transplantation Market by Type
- 4.1 Global Tissue and Organ Transplantation Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Tissue and Organ Transplantation Market Size by Type (2021-2032)
- 4.3 Global Tissue and Organ Transplantation Market Size Share by Type (2021-2032)
5 Tissue and Organ Transplantation Market by Application
- 5.1 Global Tissue and Organ Transplantation Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Tissue and Organ Transplantation Market Size by Application (2021-2032)
- 5.3 Global Tissue and Organ Transplantation Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Arthrex
- 6.1.1 Arthrex Company Information
- 6.1.2 Arthrex Business Overview
- 6.1.3 Arthrex Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Arthrex Tissue and Organ Transplantation Product Portfolio
- 6.1.5 Arthrex Recent Developments
- 6.2 Biolife Solutions
- 6.2.1 Biolife Solutions Company Information
- 6.2.2 Biolife Solutions Business Overview
- 6.2.3 Biolife Solutions Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Biolife Solutions Tissue and Organ Transplantation Product Portfolio
- 6.2.5 Biolife Solutions Recent Developments
- 6.3 Discovery Life Sciences
- 6.3.1 Discovery Life Sciences Company Information
- 6.3.2 Discovery Life Sciences Business Overview
- 6.3.3 Discovery Life Sciences Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Discovery Life Sciences Tissue and Organ Transplantation Product Portfolio
- 6.3.5 Discovery Life Sciences Recent Developments
- 6.4 Medtronic
- 6.4.1 Medtronic Company Information
- 6.4.2 Medtronic Business Overview
- 6.4.3 Medtronic Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Medtronic Tissue and Organ Transplantation Product Portfolio
- 6.4.5 Medtronic Recent Developments
- 6.5 Stryker Corporation
- 6.5.1 Stryker Corporation Company Information
- 6.5.2 Stryker Corporation Business Overview
- 6.5.3 Stryker Corporation Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Stryker Corporation Tissue and Organ Transplantation Product Portfolio
- 6.5.5 Stryker Corporation Recent Developments
- 6.6 Teva Pharmaceuticals
- 6.6.1 Teva Pharmaceuticals Company Information
- 6.6.2 Teva Pharmaceuticals Business Overview
- 6.6.3 Teva Pharmaceuticals Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Teva Pharmaceuticals Tissue and Organ Transplantation Product Portfolio
- 6.6.5 Teva Pharmaceuticals Recent Developments
- 6.7 Veloxis Pharmaceutical
- 6.7.1 Veloxis Pharmaceutical Company Information
- 6.7.2 Veloxis Pharmaceutical Business Overview
- 6.7.3 Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Veloxis Pharmaceutical Tissue and Organ Transplantation Product Portfolio
- 6.7.5 Veloxis Pharmaceutical Recent Developments
- 6.8 Zimmer Biomet
- 6.8.1 Zimmer Biomet Company Information
- 6.8.2 Zimmer Biomet Business Overview
- 6.8.3 Zimmer Biomet Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Zimmer Biomet Tissue and Organ Transplantation Product Portfolio
- 6.8.5 Zimmer Biomet Recent Developments
- 6.9 Abbvie
- 6.9.1 Abbvie Company Information
- 6.9.2 Abbvie Business Overview
- 6.9.3 Abbvie Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Abbvie Tissue and Organ Transplantation Product Portfolio
- 6.9.5 Abbvie Recent Developments
- 6.10 Novartis
- 6.10.1 Novartis Company Information
- 6.10.2 Novartis Business Overview
- 6.10.3 Novartis Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Novartis Tissue and Organ Transplantation Product Portfolio
- 6.10.5 Novartis Recent Developments
7 North America
- 7.1 North America Tissue and Organ Transplantation Market Size (2021-2032)
- 7.2 North America Tissue and Organ Transplantation Market Size by Type
- 7.2.1 North America Tissue and Organ Transplantation Market Size by Type (2021-2026)
- 7.2.2 North America Tissue and Organ Transplantation Market Size by Type (2027-2032)
- 7.2.3 North America Tissue and Organ Transplantation Market Share by Type (2021-2032)
- 7.3 North America Tissue and Organ Transplantation Market Size by Application
- 7.3.1 North America Tissue and Organ Transplantation Market Size by Application (2021-2026)
- 7.3.2 North America Tissue and Organ Transplantation Market Size by Application (2027-2032)
- 7.3.3 North America Tissue and Organ Transplantation Market Share by Application (2021-2032)
- 7.4 North America Tissue and Organ Transplantation Market Size by Country
- 7.4.1 North America Tissue and Organ Transplantation Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 7.4.3 North America Tissue and Organ Transplantation Market Size by Country (2027-2032)
- 7.4.4 North America Tissue and Organ Transplantation Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Tissue and Organ Transplantation Market Size (2021-2032)
- 8.2 Europe Tissue and Organ Transplantation Market Size by Type
- 8.2.1 Europe Tissue and Organ Transplantation Market Size by Type (2021-2026)
- 8.2.2 Europe Tissue and Organ Transplantation Market Size by Type (2027-2032)
- 8.2.3 Europe Tissue and Organ Transplantation Market Share by Type (2021-2032)
- 8.3 Europe Tissue and Organ Transplantation Market Size by Application
- 8.3.1 Europe Tissue and Organ Transplantation Market Size by Application (2021-2026)
- 8.3.2 Europe Tissue and Organ Transplantation Market Size by Application (2027-2032)
- 8.3.3 Europe Tissue and Organ Transplantation Market Share by Application (2021-2032)
- 8.4 Europe Tissue and Organ Transplantation Market Size by Country
- 8.4.1 Europe Tissue and Organ Transplantation Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 8.4.3 Europe Tissue and Organ Transplantation Market Size by Country (2027-2032)
- 8.4.4 Europe Tissue and Organ Transplantation Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Tissue and Organ Transplantation Market Size (2021-2032)
- 9.2 China Tissue and Organ Transplantation Market Size by Type
- 9.2.1 China Tissue and Organ Transplantation Market Size by Type (2021-2026)
- 9.2.2 China Tissue and Organ Transplantation Market Size by Type (2027-2032)
- 9.2.3 China Tissue and Organ Transplantation Market Share by Type (2021-2032)
- 9.3 China Tissue and Organ Transplantation Market Size by Application
- 9.3.1 China Tissue and Organ Transplantation Market Size by Application (2021-2026)
- 9.3.2 China Tissue and Organ Transplantation Market Size by Application (2027-2032)
- 9.3.3 China Tissue and Organ Transplantation Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Tissue and Organ Transplantation Market Size (2021-2032)
- 10.2 Asia Tissue and Organ Transplantation Market Size by Type
- 10.2.1 Asia Tissue and Organ Transplantation Market Size by Type (2021-2026)
- 10.2.2 Asia Tissue and Organ Transplantation Market Size by Type (2027-2032)
- 10.2.3 Asia Tissue and Organ Transplantation Market Share by Type (2021-2032)
- 10.3 Asia Tissue and Organ Transplantation Market Size by Application
- 10.3.1 Asia Tissue and Organ Transplantation Market Size by Application (2021-2026)
- 10.3.2 Asia Tissue and Organ Transplantation Market Size by Application (2027-2032)
- 10.3.3 Asia Tissue and Organ Transplantation Market Share by Application (2021-2032)
- 10.4 Asia Tissue and Organ Transplantation Market Size by Country
- 10.4.1 Asia Tissue and Organ Transplantation Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 10.4.3 Asia Tissue and Organ Transplantation Market Size by Country (2027-2032)
- 10.4.4 Asia Tissue and Organ Transplantation Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Tissue and Organ Transplantation Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Tissue and Organ Transplantation Market Size by Type
- 11.2.1 South America, Middle East & Africa Tissue and Organ Transplantation Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Tissue and Organ Transplantation Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Tissue and Organ Transplantation Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Tissue and Organ Transplantation Market Size by Application
- 11.3.1 South America, Middle East & Africa Tissue and Organ Transplantation Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Tissue and Organ Transplantation Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Tissue and Organ Transplantation Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Tissue and Organ Transplantation Market Size by Country
- 11.4.1 South America, Middle East & Africa Tissue and Organ Transplantation Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Tissue and Organ Transplantation Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Tissue and Organ Transplantation Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst